切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2018, Vol. 12 ›› Issue (05) : 292 -296. doi: 10.3877/cma.j.issn.1674-0793.2018.05.002

所属专题: 文献

述评

肝细胞癌微血管侵犯研究对外科肿瘤学切缘的启示
鞠明光1, 徐锋1, 戴朝六1   
  1. 1. 110004 沈阳,中国医科大学附属盛京医院第五普通外科
  • 收稿日期:2018-08-01 出版日期:2018-10-01
  • 基金资助:
    辽宁省科学技术计划项目(2017225032); 沈阳市科技计划项目(17-230-9-16)

Implications of microvascular invasion in the oncological margins of hepatocellular carcinoma

Mingguang Ju1, Feng Xu1, Chaoliu Dai1   

  • Received:2018-08-01 Published:2018-10-01
引用本文:

鞠明光, 徐锋, 戴朝六. 肝细胞癌微血管侵犯研究对外科肿瘤学切缘的启示[J]. 中华普通外科学文献(电子版), 2018, 12(05): 292-296.

Mingguang Ju, Feng Xu, Chaoliu Dai. Implications of microvascular invasion in the oncological margins of hepatocellular carcinoma[J]. Chinese Archives of General Surgery(Electronic Edition), 2018, 12(05): 292-296.

[1]
Liu B, Long J, Wang W, et al. Treatment of hepatocellular carcinoma in the caudate lobe: US-guided percutaneous radiofrequency ablation combined with ethanol ablation[J]. Clin Radiol, 2018,73(7):647-656.
[2]
戴朝六,贾昌俊. 以外科手术为主的肝癌多学科综合治疗[J]. 腹部外科, 2017,30(2):79-84.
[3]
Hirokawa F, Hayashi M, Miyamoto Y, et al. Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma[J]. Hepatol Res, 2014,44(8):846-853.
[4]
Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver[J]. Ann Surg, 2011,253(4):656-665.
[5]
Hwang S, Lee YJ, Kim KH, et al. Long-term outcome after resection of huge hepatocellular carcinoma ≥10 cm: single-institution experience with 471 patients[J]. World J Surg, 2015,39(10):2519-2528.
[6]
Zhong FP, Zhang YJ, Liu Y, et al. Prognostic impact of surgical margin in patients with hepatocellular carcinoma: A meta-analysis[J]. Medicine (Baltimore), 2017,96(37):e8043.
[7]
中华人民共和国国家卫生和计划生育委员会. 原发性肝癌诊疗规范(2017年版)[J]. 临床肝胆病杂志, 2017,33(8):1419-1431.
[8]
刘臻玉,武丹,区锦玲, 等. 肝癌微血管侵犯的特点及相关临床指标[J]. 肝胆胰外科杂志, 2017,25(2):107-111.
[9]
Imai K, Yamashita YI, Yusa T, et al. Microvascular invasion in small-sized hepatocellular carcinoma: significance for outcomes following hepatectomy and radiofrequency ablation[J]. Anticancer Res, 2018,38(2):1053-1060.
[10]
Zheng J, Seier K, Gonen M, et al. Utility of serum inflammatory markers for predicting microvascular invasion and survival for patients with hepatocellular carcinoma[J]. Ann Surg Oncol, 2017,24(12):3706-3714.
[11]
Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, et al. Impact of surgical margin width on recurrence and overall survival following R0 hepatic resection of colorectal metastases: a systematic review and meta-analysis[J]. Ann Surg, 2018,267(6):1047-1055.
[12]
Beppu T, Imai K, Okuda K, et al. Anterior approach for right hepatectomy with hanging maneuver for hepatocellular carcinoma: a multi-institutional propensity score-matching study[J]. J Hepatobiliary Pancreat Sci, 2017,24(3):127-136.
[13]
Chen L, Guo P, He Y, et al. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway[J]. Cell Death Dis, 2018,9(5):513.
[14]
Xu ZY, Ding SM, Zhou L, et al. FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition[J]. Int J Biol Sci, 2012,8(8):1130-1141.
[15]
Wang X, Ma C, Zong Z, et al. A20 inhibits the motility of HCC cells induced by TNF-alpha[J]. Oncotarget, 2016,7(12):14742-14754.
[16]
Liu J, Zhu Q, Li Y, et al. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study[J]. Clin Res Hepatol Gastroenterol, 2018,pii:S2210-7401(18):30036-6.
[17]
Wei X, Li N, Li S, et al. Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma[J]. BMC Cancer, 2017,17(1):304.
[18]
Yang C, Wang H, Sheng R, et al. Microvascular invasion in hepatocellular carcinoma: is it predictable with a new, preoperative application of diffusion-weighted imaging?[J]. Clin Imaging, 2017,41:101-105.
[19]
张小峰,汪宇,王文超, 等. 微血管侵犯在肝癌外科治疗中的临床意义[J]. 肝胆外科杂志, 2017,25(1):7-10.
[20]
Zhao H, Hua Y, Dai T, et al. Development and validation of a novel predictive scoring model for microvascular invasion in patients with hepatocellular carcinoma[J]. Eur J Radiol, 2017,88:32-40.
[21]
Shirabe K, Toshima T, Kimura K, et al. New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma[J]. Liver Int, 2014,34(6):937-941.
[22]
Huang C, Zhu XD, Ji Y, et al. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B[J]. BMC Cancer, 2017,17(1):58.
[23]
Shindoh J, Hasegawa K, Inoue Y, et al. Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma[J]. HPB (Oxford), 2013,15(1):31-39.
[24]
Eguchi S, Kanematsu T, Arii S, et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey[J]. Surgery, 2008,143(4):469-475.
[25]
Ye JZ, Miao ZG, Wu FX, et al. Recurrence after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis[J]. Asian Pac J Cancer Prev, 2012,13(5):1771-1777.
[26]
Higaki T, Takayama T, Midorikawa Y. Ventral approach for resecting hepatocellular carcinoma in the caval portion of the caudate lobe[J]. Surgery, 2018,163(6):1245-1249.
[27]
Orcutt ST, Anaya DA. Liver resection and surgical strategies for management of primary liver cancer[J]. Cancer Control, 2018,25(1):1145179885.
[28]
Nakashima Y, Nakashima O, Tanaka M, et al. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type[J]. Hepatol Res, 2003,26(2):142-147.
[29]
陈敏山,潘扬勋. 小肝癌的多学科微创治疗进展[J]. 中国普外基础与临床杂志, 2018,34(4):396-400.
[30]
Feng LH, Dong H, Lau WY, et al. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2017,143(2):293-303.
[31]
Du M, Chen L, Zhao J, et al. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma[J]. BMC Cancer, 2014,14:38.
[32]
Lafaro K, Grandhi MS, Herman JM, et al. The importance of surgical margins in primary malignancies of the liver[J]. J Surg Oncol, 2016,113(3):296-303.
[33]
Hu HT, Wang Z, Kuang M, et al. Need for normalization: the non-standard reference standard for microvascular invasion diagnosis in hepatocellular carcinoma[J]. World J Surg Oncol, 2018,16(1):50.
[34]
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2):87-108.
[35]
Feng LH, Dong H, Lau WY, et al. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2017,143(2):293-303.
No related articles found!
阅读次数
全文


摘要